Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10006749984
Persistent link: https://www.econbiz.de/10006836664
Persistent link: https://www.econbiz.de/10009959338
Persistent link: https://www.econbiz.de/10009959343
Persistent link: https://www.econbiz.de/10007431185
Background: To obtain detailed real-life data on costs and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in patients treated in Switzerland. Methods: Administrative claims processed by a major Swiss health insurer between 2005 and 2008 were...
Persistent link: https://www.econbiz.de/10010148171
Persistent link: https://www.econbiz.de/10007800942
Persistent link: https://www.econbiz.de/10008068722
Persistent link: https://www.econbiz.de/10008232227
Persistent link: https://www.econbiz.de/10006762983